Daniel Isaza

Here are the 2 accompanying editorials, diametrically opposed!

STEMI-DTU trial: Combination of the Impella CP plus device a 30-minute delay to PCI did not reduce infarct size vs. immediate PCI in patients with anterior STEMI without shock. #ACC26 View slides here: clinicaltrialresults.org/wp-content/upl…

Presented at #ACC26: In patients with atrial fibrillation, left atrial appendage closure was noninferior to NOACs in an analysis of death from cardiovascular causes, stroke, or systemic embolism and was superior for non–procedure-related bleeding. Full CHAMPION-AF trial results: nejm.org/doi/full/10.10… Editorial: Left Atrial Appendage Closure — Should Recommendations Be Expanded? nejm.org/doi/full/10.10… @ACCinTouch

The Big Shift in Cardiology to Atheroma and Inflammation erictopol.substack.com/p/the-big-shif…

The era of the GLP-1 family of drugs is still in the early days. These gut peptides talk to the brain and immune system and there are so many more in development, in combination, in pills, to come.

Wonderful to host @DrCaliff_FDA - our visiting "chief provocateur" - for @SmithBIDMC Grand Rounds @BidmcCvi A rich and thought-provoking discussion on health care, social inequality, public health, and the role of communication & trust.

Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology | JACC jacc.org/doi/10.1016/j.…

@ChrisKramerMD high yield talk (a thread 1/4) AN(O)CA, INOCA & MINOCA – umbrella terms for patients with non-obstructive CAD (<50% stenosis). •MINOCA: MI + troponin elevation + angina •INOCA: Ischemia + angina, no troponin •ANOCA: Angina only #ACCMidEast @ACCinTouch

🚨 A new, practical framework for evaluating the economic value of cardiovascular drugs, devices, and preventive strategies Just published in @JACCJournals and @CircAHA Here’s what’s new, why it matters, and how it will shape care. 🧵

🙌 Muchas gracias a toda la comunidad de @fcardioinfantil por la invitación. Un placer poder participar junto a @Drlipid

Dr Pablo Corral @drpablocorral 🇦🇷en conferencia acerca de Lipoproteina (a) en @fcardioinfantil 🇨🇴

2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement): A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | JACC jacc.org/doi/10.1016/j.…

#ESCCongressVisuals from Hot Line 8👇 Will the ALONE-AF trial demonstrate that patients with AF who have at least one non-gender stroke risk factor & no documented recurrence of AF after 12 months receiving apixaban have a lower composite of stroke, systemic embolism and bleeding? 👇 PFA has gained traction given its simplicity recently. Will the BEAT PAROX AF trial prove that this technology provides superior results compared with the previously employed ablation techniques? 👇 Are we charting the future of more precise ablation using digital twin-guided rotor ablation? The CUVIA-PRR brings the future to us today. 👇 #ESCCongress

2025 ESC Guidelines for the management of myocarditis and pericarditis | European Heart Journal | Oxford Academic academic.oup.com/eurheartj/adva…

@ISACHD #Case of the #Month Congratulations to 🇨🇴 team @fcardioinfantil 1/ 🫀 A 27-year-old woman with a history of dextro-transposition of the great arteries (D-TGA) repaired by Mustard procedure as an infant develops worsening shortness of breath. What happened next shows the power of multimodal imaging & multidisciplinary teamwork. #CardioTwitter #ACHD

Right now at #ESC2025 @escardio

Beta-Blocker Therapy Following MI the Focus of Late-Breaking Research at ESC Congress 2025 - American College of Cardiology acc.org/Latest-in-Card…

@jsenior64 Para ayudarlo a confundir. En Dinamarca 🇩🇰 y Noruega 🇳🇴 si protegen. nejm.org/doi/full/10.10…

#ESCCongress 2025 La replicabilidad de los estudios reduce la incertidumbre en los resultados. ¿Cómo reconciliar estudios con resultados contradictorios? BB posinfarto: ¿por la FEVI >50% <40%, por la intervención? ¿Síntomas de falla cardiaca? Alguna idea? nejm.org/doi/full/10.10…

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure | New England Journal of Medicine nejm.org/doi/full/10.10…

🚨 Today @worldheartfed launched its new Roadmap on Single Pill Combination Therapies at #ESCCongress with #WCCardio! By combining medicines into one pill, we can improve adherence and save lives. Learn more: bit.ly/3JGmLsk